Analyst Salveen Richter works at GOLDMAN SACHS and is focused on the Healthcare sector with 496 price targets and ratings documented since 2012 spanning on 38 stocks. Analyst's average stock valuation to be materialised ratio is 61.76% with an average time for price targets to be met of 149.5 days.
Most recent stock forecast was given on QURE, uniQure N.V at 23-Nov-2022.
Salveen Richter best performing recommendations are on DTIL.
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS, INC) at 11/18/2019. The price target of $109 was fulfilled within 1 day with a profit of $13 (13.54%) receiving and performance score of 135.42.
Average potential price target upside